Skip to content
Subscriber Only

Better Therapeutics Agrees to Go Public Via Mountain Crest SPAC

Updated on

Better Therapeutics Inc., a company that helps treat patients with smartphone apps, agreed to go public through a merger with a blank-check company Mountain Crest Acquisition Corp II.

The deal values San Francisco-based Better Therapeutics at $187 million, including debt, according to a statement Wednesday, confirming a Bloomberg News report. The deal also includes a $50 million private investment in public equity from investors including Farallon Capital Management, RS Investments, Sectoral Asset Management, and Monashee Investment Management.